<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32986860</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5381</ISSN><JournalIssue CitedMedium="Internet"><Volume>178</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of pharmacology</Title><ISOAbbreviation>Br J Pharmacol</ISOAbbreviation></Journal><ArticleTitle>What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy.</ArticleTitle><Pagination><StartPage>1279</StartPage><EndPage>1297</EndPage><MedlinePgn>1279-1297</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bph.15276</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an adult onset disorder characterized by progressive neuromuscular junction (NMJ) dismantling and degeneration of motor neurons leading to atrophy and paralysis of voluntary muscles responsible for motion and breathing. Except for a minority of patients harbouring genetic mutations, the origin of most ALS cases remains elusive. Peripheral tissues, and particularly skeletal muscle, have lately demonstrated an active contribution to disease pathology attracting a growing interest for these tissues as therapeutic targets in ALS. In this sense, molecular mechanisms essential for cell and tissue homeostasis have been shown to be deregulated in the disease. These include muscle metabolism and mitochondrial activity, RNA processing, tissue-resident stem cell function responsible for muscle regeneration, and proteostasis that regulates muscle mass in adulthood. This review aims to compile scientific evidence that demonstrates the role of skeletal muscle in ALS pathology and serves as reference for development of novel therapeutic strategies targeting this tissue to delay disease onset and progression. LINKED ARTICLES: This article is part of a themed issue on Neurochemistry in Japan. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.6/issuetoc.</AbstractText><CopyrightInformation>&#xa9; 2020 British Pharmacological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manzano</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toivonen</LastName><ForeName>Janne Markus</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Mart&#xed;nez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Torre</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Garc&#xed;a</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Royo</LastName><ForeName>Tresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatrics Service, Hospital Nuestra Se&#xf1;ora de Gracia, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaragoza</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Ana Cristina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Embryology and Animal Genetics, University of Zaragoza, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Agroalimentary Institute of Aragon (IA2), Institute of Health Research of Aragon (IIS), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>752349</GrantID><Agency>Horizon 2020 Framework Programme</Agency><Country/></Grant><Grant><Agency>Gobierno de Arag&#xf3;n</Agency><Country/></Grant><Grant><GrantID>CB18/05/00037</GrantID><Agency>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas</Agency><Country/></Grant><Grant><Agency>European Regional Development Fund</Agency><Country/></Grant><Grant><GrantID>PI17/00949</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Pharmacol</MedlineTA><NlmUniqueID>7502536</NlmUniqueID><ISSNLinking>0007-1188</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA metabolism</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cellular repair mechanisms</Keyword><Keyword MajorTopicYN="N">intercellular signalling</Keyword><Keyword MajorTopicYN="N">neurodegeneration/neuroprotection</Keyword><Keyword MajorTopicYN="N">proteostasis</Keyword><Keyword MajorTopicYN="N">regeneration</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>28</Day><Hour>17</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32986860</ArticleId><ArticleId IdType="doi">10.1111/bph.15276</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Acevedo-Arozena, A., Kalmar, B., Essa, S., Ricketts, T., Joyce, P., Kent, R., &#x2026; Fisher, E. M. (2011). A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis. Disease Models &amp; Mechanisms, 4(5), 686-700. https://doi.org/10.1242/dmm.007237</Citation></Reference><Reference><Citation>Alami, N. H., Smith, R. B., Carrasco, M. A., Williams, L. A., Winborn, C. S., Han, S. S. W., &#x2026; Taylor, J. P. (2014). Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron, 81(3), 536-543. https://doi.org/10.1016/j.neuron.2013.12.018</Citation></Reference><Reference><Citation>Al-Chalabi, A., &amp; Hardiman, O. (2013). The epidemiology of ALS: A conspiracy of genes, environment and time. Nature Reviews Neurology, 9(11), 617-628. https://doi.org/10.1038/nrneurol.2013.203</Citation></Reference><Reference><Citation>Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., &#x2026; CGTP Collaborators. (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology, 176, S21-S141. https://doi.org/10.1111/bph.14748</Citation></Reference><Reference><Citation>Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., &#x2026; CGTP Collaborators. (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes. British Journal of Pharmacology, 176, S297-S396. https://doi.org/10.1111/bph.14752</Citation></Reference><Reference><Citation>Alexander, S. P. H., Mathie, A., Peters, J. A., Veale, E. L., Striessnig, J., Kelly, E., &#x2026; CGTP Collaborators. (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology, 176, S142-S228. https://doi.org/10.1111/bph.14749</Citation></Reference><Reference><Citation>An, H., Tan, J. T., &amp; Shelkovnikova, T. A. (2019). Stress granules regulate stress-induced paraspeckle assembly. The Journal of Cell Biology, 218(12), 4127-4140. https://doi.org/10.1083/jcb.201904098</Citation></Reference><Reference><Citation>Anthony, T. G. (2016). Mechanisms of protein balance in skeletal muscle. Domestic Animal Endocrinology, 56(Suppl), S23-S32. https://doi.org/10.1016/j.domaniend.2016.02.012</Citation></Reference><Reference><Citation>Aoki, Y., Manzano, R., Lee, Y., Dafinca, R., Aoki, M., Douglas, A. G. L., &#x2026; Wood, M. J. A. (2017). C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain, 140(4), 887-897. https://doi.org/10.1093/brain/awx024</Citation></Reference><Reference><Citation>Artuso, L., Zoccolella, S., Favia, P., Amati, A., Capozzo, R., Logroscino, G., &#x2026; Petruzzella, V. (2013). Mitochondrial genome aberrations in skeletal muscle of patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener, 14(4), 261-266. https://doi.org/10.3109/21678421.2012.735239</Citation></Reference><Reference><Citation>Aurelian, L., Laing, J. M., &amp; Lee, K. S. (2012). H11/HspB8 and its herpes simplex virus type 2 homologue ICP10PK share functions that regulate cell life/death decisions and human disease. Autoimmune Diseases, 2012, 395329-395329. https://doi.org/10.1155/2012/395329</Citation></Reference><Reference><Citation>Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A., Kingsman, S. M., &#x2026; Mazarakis, N. D. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 429(6990), 413-417. https://doi.org/10.1038/nature02544</Citation></Reference><Reference><Citation>Banerjee, A., Vest, K. E., Pavlath, G. K., &amp; Corbett, A. H. (2017). Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing. Nucleic Acids Research, 45(18), 10706-10725. https://doi.org/10.1093/nar/gkx786</Citation></Reference><Reference><Citation>Barker, H. V., Niblock, M., Lee, Y. B., Shaw, C. E., &amp; Gallo, J. M. (2017). RNA misprocessing in C9orf72-linked neurodegeneration. Frontiers in Cellular Neuroscience, 11, 195. https://doi.org/10.3389/fncel.2017.00195</Citation></Reference><Reference><Citation>Bella, E. D., Tramacere, I., Antonini, G., Borghero, G., Capasso, M., Caponnetto, C., &#x2026; Lauria, G. (2017). Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial). BMJ Open, 7(8), e015434. https://doi.org/10.1136/bmjopen-2016-015434</Citation></Reference><Reference><Citation>Bhattacharya, A., Wei, R., Hamilton, R. T., &amp; Chaudhuri, A. R. (2014). Neuronal cells but not muscle cells are resistant to oxidative stress mediated protein misfolding and cell death: Role of molecular chaperones. Biochemical and Biophysical Research Communications, 446(4), 1250-1254. https://doi.org/10.1016/j.bbrc.2014.03.097</Citation></Reference><Reference><Citation>Boillee, S., Vande Velde, C., &amp; Cleveland, D. W. (2006). ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron, 52(1), 39-59. https://doi.org/10.1016/j.neuron.2006.09.018</Citation></Reference><Reference><Citation>Boillee, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., &#x2026; Cleveland, D. W. (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 312(5778), 1389-1392. https://doi.org/10.1126/science.1123511</Citation></Reference><Reference><Citation>Borasio, G. D., Robberecht, W., Leigh, P. N., Emile, J., Guiloff, R. J., Jerusalem, F., &#x2026; European ALS/IGF-I Study Group. (1998). A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. Neurology, 51(2), 583-586. https://doi.org/10.1212/wnl.51.2.583</Citation></Reference><Reference><Citation>Bouteloup, C., Desport, J. C., Clavelou, P., Guy, N., Derumeaux-Burel, H., Ferrier, A., &amp; Couratier, P. (2009). Hypermetabolism in ALS patients: An early and persistent phenomenon. Journal of Neurology, 256(8), 1236-1242. https://doi.org/10.1007/s00415-009-5100-z</Citation></Reference><Reference><Citation>Braga, A. C. M., Pinto, A., Pinto, S., &amp; de Carvalho, M. (2018). The role of moderate aerobic exercise as determined by cardiopulmonary exercise testing in ALS. Neurology Research International, 2018, 8218697-8218697. https://doi.org/10.1155/2018/8218697</Citation></Reference><Reference><Citation>Bros-Facer, V., Krull, D., Taylor, A., Dick, J. R., Bates, S. A., Cleveland, M. S., &#x2026; Greensmith, L. (2014). Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis. Human Molecular Genetics, 23(16), 4187-4200. https://doi.org/10.1093/hmg/ddu136</Citation></Reference><Reference><Citation>Bruneteau, G., Bauche, S., Gonzalez de Aguilar, J. L., Brochier, G., Mandjee, N., Tanguy, M. L., &#x2026; Hantai, D. (2015). Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Annals of Clinical Translational Neurology, 2(4), 362-372. https://doi.org/10.1002/acn3.179</Citation></Reference><Reference><Citation>Bruneteau, G., Simonet, T., Bauch&#xe9;, S., Mandjee, N., Malfatti, E., Girard, E., &#x2026; Hanta&#xef;, D. (2013). Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: Potential role in reinnervation ability and disease progression. Brain, 136(Pt 8), 2359-2368. https://doi.org/10.1093/brain/awt164</Citation></Reference><Reference><Citation>Butti, Z., &amp; Patten, S. A. (2019). RNA dysregulation in amyotrophic lateral sclerosis. Frontiers in Genetics, 9, 712.</Citation></Reference><Reference><Citation>Byrne, S., Walsh, C., Lynch, C., Bede, P., Elamin, M., Kenna, K., &#x2026; Hardiman, O. (2011). Rate of familial amyotrophic lateral sclerosis: A systematic review and meta-analysis. Journal of Neurology, Neurosurgery &amp; Psychiatry, 82(6), 623. https://doi.org/10.1136/jnnp.2010.224501</Citation></Reference><Reference><Citation>Caroni, P., &amp; Grandes, P. (1990). Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. The Journal of Cell Biology, 110(4), 1307-1317. https://doi.org/10.1083/jcb.110.4.1307</Citation></Reference><Reference><Citation>Carrasco, D. I., Bichler, E. K., Seburn, K. L., &amp; Pinter, M. J. (2010). Nerve terminal degeneration is independent of muscle fiber genotype in SOD1 mice. PLoS ONE, 5(3), e9802. https://doi.org/10.1371/journal.pone.0009802</Citation></Reference><Reference><Citation>Castanotto, D., Zhang, X., Alluin, J., R&#xfc;ger, J., Armstrong, B., Rossi, J., &#x2026; Stein, C. A. (2018). A stress-induced response complex (SIRC) shuttles miRNAs, siRNAs, and oligonucleotides to the nucleus. Proceedings of the National Academy of Sciences of the United States of America, 115(25), E5756-e5765. https://doi.org/10.1073/pnas.1721346115</Citation></Reference><Reference><Citation>Cestra, G., Rossi, S., Di Salvio, M., &amp; Cozzolino, M. (2017). Control of mRNA translation in ALS proteinopathy. Frontiers in Molecular Neuroscience, 10, 85-85. https://doi.org/10.3389/fnmol.2017.00085</Citation></Reference><Reference><Citation>Chen, D., Wang, Y., &amp; Chin, E. R. (2015). Activation of the endoplasmic reticulum stress response in skeletal muscle of G93A*SOD1 amyotrophic lateral sclerosis mice. Frontiers in Cellular Neuroscience, 9, 170. https://doi.org/10.3389/fncel.2015.00170</Citation></Reference><Reference><Citation>Chen, L., Chen, D., Xi, H., Wang, Q., Liu, Y., Zhang, F., &#x2026; Huang, H. (2012). Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: Benefits from multiple transplantations. Cell Transplantation, 21(Suppl 1), S65-S77. https://doi.org/10.3727/096368912x633789</Citation></Reference><Reference><Citation>Chen, L., Huang, H., Zhang, J., Zhang, F., Liu, Y., Xi, H., &#x2026; Tan, K. (2007). Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery, 21(9), 961-966.</Citation></Reference><Reference><Citation>Ching, J. K., Elizabeth, S. V., Ju, J. S., Lusk, C., Pittman, S. K., &amp; Weihl, C. C. (2013). mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy. Human Molecular Genetics, 22(6), 1167-1179. https://doi.org/10.1093/hmg/dds524</Citation></Reference><Reference><Citation>Chung, M. J., &amp; Suh, Y.-L. (2002). Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastructural Pathology, 26(1), 3-7. https://doi.org/10.1080/01913120252934260</Citation></Reference><Reference><Citation>Cicardi, M. E., Cristofani, R., Rusmini, P., Meroni, M., Ferrari, V., Vezzoli, G., &#x2026; Poletti, A. (2018). Tdp-25 routing to autophagy and proteasome ameliorates its aggregation in amyotrophic lateral sclerosis target cells. Scientific Reports, 8(1), 12390. https://doi.org/10.1038/s41598-018-29658-2</Citation></Reference><Reference><Citation>Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillee, S., Rule, M., &#x2026; Cleveland, D. W. (2003). Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science, 302(5642), 113-117. https://doi.org/10.1126/science.1086071</Citation></Reference><Reference><Citation>Crippa, V., Boncoraglio, A., Galbiati, M., Aggarwal, T., Rusmini, P., Giorgetti, E., &#x2026; Poletti, A. (2013). Differential autophagy power in the spinal cord and muscle of transgenic ALS mice. Frontiers in Cellular Neuroscience, 7, 234. https://doi.org/10.3389/fncel.2013.00234</Citation></Reference><Reference><Citation>Crugnola, V., Lamperti, C., Lucchini, V., Ronchi, D., Peverelli, L., Prelle, A., &#x2026; Moggio, M. (2010). Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Archives of Neurology, 67(7), 849-854. https://doi.org/10.1001/archneurol.2010.128</Citation></Reference><Reference><Citation>Cykowski, M. D., Dickson, D. W., Powell, S. Z., Arumanayagam, A. S., Rivera, A. L., &amp; Appel, S. H. (2019). Dipeptide repeat (DPR) pathology in the skeletal muscle of ALS patients with C9ORF72 repeat expansion. Acta Neuropathologica, 138(4), 667-670. https://doi.org/10.1007/s00401-019-02050-8</Citation></Reference><Reference><Citation>Cykowski, M. D., Powell, S. Z., Appel, J. W., Arumanayagam, A. S., Rivera, A. L., &amp; Appel, S. H. (2018). Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathologica Communications, 6(1), 28. https://doi.org/10.1186/s40478-018-0528-y</Citation></Reference><Reference><Citation>Deforges, S., Branchu, J., Biondi, O., Grondard, C., Pariset, C., L&#xe9;colle, S., &#x2026; Charbonnier, F. (2009). Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. The Journal of Physiology, 587(Pt 14), 3561-3572. https://doi.org/10.1113/jphysiol.2009.169748</Citation></Reference><Reference><Citation>Derave, W., Van Den Bosch, L., Lemmens, G., Eijnde, B. O., Robberecht, W., &amp; Hespel, P. (2003). Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: Effects of creatine treatment. Neurobiology of Disease, 13(3), 264-272. https://doi.org/10.1016/s0969-9961(03)00041-x</Citation></Reference><Reference><Citation>Di Pietro, L., Lattanzi, W., &amp; Bernardini, C. (2018). Skeletal muscle microRNAs as key players in the pathogenesis of amyotrophic lateral sclerosis. International Journal of Molecular Sciences, 19(5). https://doi.org/10.3390/ijms19051534</Citation></Reference><Reference><Citation>Dobrowolny, G., Aucello, M., Rizzuto, E., Beccafico, S., Mammucari, C., Boncompagni, S., &#x2026; Musar&#xf2;, A. (2008). Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metabolism, 8(5), 425-436. https://doi.org/10.1016/j.cmet.2008.09.002</Citation></Reference><Reference><Citation>Dobrowolny, G., Giacinti, C., Pelosi, L., Nicoletti, C., Winn, N., Barberi, L., &#x2026; Musar&#xf2;, A. (2005). Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. The Journal of Cell Biology, 168(2), 193-199. https://doi.org/10.1083/jcb.200407021</Citation></Reference><Reference><Citation>Dobrowolny, G., Lepore, E., Martini, M., Barberi, L., Nunn, A., Scicchitano, B. M., &amp; Musar&#xf2;, A. (2018). Metabolic changes associated with muscle expression of SOD1G93A. Frontiers in Physiology, 9, 831-831. https://doi.org/10.3389/fphys.2018.00831</Citation></Reference><Reference><Citation>Dolinar, A., Koritnik, B., Glava&#x10d;, D., &amp; Ravnik-Glava&#x10d;, M. (2019). Circular RNAs as potential blood biomarkers in amyotrophic lateral sclerosis. Molecular Neurobiology, 56(12), 8052-8062. https://doi.org/10.1007/s12035-019-1627-x</Citation></Reference><Reference><Citation>Dreser, A., Vollrath, J. T., Sechi, A., Johann, S., Roos, A., Yamoah, A., &#x2026; Goswami, A. (2017). The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death and Differentiation, 24(10), 1655-1671. https://doi.org/10.1038/cdd.2017.88</Citation></Reference><Reference><Citation>Dupuis, L., Oudart, H., Ren&#xe9;, F., Gonzalez de Aguilar, J. L., &amp; Loeffler, J. P. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America, 101(30), 11159-11164. https://doi.org/10.1073/pnas.0402026101</Citation></Reference><Reference><Citation>Fabbrizio, P., Apolloni, S., Bianchi, A., Salvatori, I., Valle, C., Lanzuolo, C., &#x2026; Volont&#xe9;, C. (2019). P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Brain Pathology (Zurich, Switzerland). https://doi.org/10.1111/bpa.12774</Citation></Reference><Reference><Citation>Fergani, A., Oudart, H., Gonzalez De Aguilar, J.-L., Fricker, B., Ren&#xe9;, F., Hocquette, J.-F., &#x2026; Loeffler, J.-P. (2007). Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. Journal of Lipid Research, 48(7), 1571-1580. https://doi.org/10.1194/jlr.M700017-JLR200</Citation></Reference><Reference><Citation>Ferraiuolo, L., Meyer, K., Sherwood, T. W., Vick, J., Likhite, S., Frakes, A., &#x2026; Kaspar, B. K. (2016). Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proceedings of the National Academy of Sciences of the United States of America, 113(42), E6496-E6505. https://doi.org/10.1073/pnas.1607496113</Citation></Reference><Reference><Citation>Ferri, A., &amp; Coccurello, R. (2017). What is &#x201c;hyper&#x201d; in the ALS hypermetabolism? Mediators of Inflammation, 2017, 7821672-7821672. https://doi.org/10.1155/2017/7821672</Citation></Reference><Reference><Citation>Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., &#x2026; Glass, J. D. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Experimental Neurology, 185(2), 232-240. https://doi.org/10.1016/j.expneurol.2003.10.004</Citation></Reference><Reference><Citation>Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., Lee, K.-H., &#x2026; Taylor, J. P. (2015). GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature, 525(7567), 129-133. https://doi.org/10.1038/nature14974</Citation></Reference><Reference><Citation>Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W., &amp; Caroni, P. (2000). Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. The Journal of Neuroscience, 20(7), 2534-2542.</Citation></Reference><Reference><Citation>Gonzalez, D., Contreras, O., Rebolledo, D. L., Espinoza, J. P., van Zundert, B., &amp; Brandan, E. (2017). ALS skeletal muscle shows enhanced TGF-&#x3b2; signaling, fibrosis and induction of fibro/adipogenic progenitor markers. PLoS ONE, 12(5), e0177649. https://doi.org/10.1371/journal.pone.0177649</Citation></Reference><Reference><Citation>Gould, T. W., Buss, R. R., Vinsant, S., Prevette, D., Sun, W., Knudson, C. M., &#x2026; Oppenheim, R. W. (2006). Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. The Journal of Neuroscience, 26(34), 8774-8786. https://doi.org/10.1523/JNEUROSCI.2315-06.2006</Citation></Reference><Reference><Citation>Hadzipasic, M., Tahvildari, B., Nagy, M., Bian, M., Horwich, A. L., &amp; McCormick, D. A. (2014). Selective degeneration of a physiological subtype of spinal motor neuron in mice with SOD1-linked ALS. Proceedings of the National Academy of Sciences of the United States of America, 111(47), 16883-16888. https://doi.org/10.1073/pnas.1419497111</Citation></Reference><Reference><Citation>Han, S. M., El Oussini, H., Scekic-Zahirovic, J., Vibbert, J., Cottee, P., Prasain, J. K., &#x2026; Miller, M. A. (2013). VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in Caenorhabditis elegans. PLoS Genetics, 9(9), e1003738. https://doi.org/10.1371/journal.pgen.1003738</Citation></Reference><Reference><Citation>Hegedus, J., Putman, C. T., &amp; Gordon, T. (2007). Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease, 28(2), 154-164. https://doi.org/10.1016/j.nbd.2007.07.003</Citation></Reference><Reference><Citation>Hegedus, J., Putman, C. T., Tyreman, N., &amp; Gordon, T. (2008). Preferential motor unit loss in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis. The Journal of Physiology, 586(14), 3337-3351. https://doi.org/10.1113/jphysiol.2007.149286</Citation></Reference><Reference><Citation>Heredia, J. E., Mukundan, L., Chen, F. M., Mueller, A. A., Deo, R. C., Locksley, R. M., &#x2026; Chawla, A. (2013). Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell, 153(2), 376-388. https://doi.org/10.1016/j.cell.2013.02.053</Citation></Reference><Reference><Citation>Huang, H., Chen, L., Xi, H., Wang, H., Zhang, J., Zhang, F., &amp; Liu, Y. (2008). Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: A controlled pilot study. Clinical Transplantation, 22(6), 710-718. https://doi.org/10.1111/j.1399-0012.2008.00865.x</Citation></Reference><Reference><Citation>Ishimoto, S., Goto, I., Ohta, M., &amp; Kuroiwa, Y. (1983). A quantitative study of the muscle satellite cells in various neuromuscular disorders. Journal of the Neurological Sciences, 62(1-3), 303-314. https://doi.org/10.1016/0022-510x(83)90207-1</Citation></Reference><Reference><Citation>Ismaeel, A., Kim, J.-S., Kirk, J. S., Smith, R. S., Bohannon, W. T., &amp; Koutakis, P. (2019). Role of transforming growth factor-&#x3b2; in skeletal muscle fibrosis: A review. International Journal of Molecular Sciences, 20(10), 2446. https://doi.org/10.3390/ijms20102446</Citation></Reference><Reference><Citation>Jaarsma, D., Teuling, E., Haasdijk, E. D., De Zeeuw, C. I., &amp; Hoogenraad, C. C. (2008). Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. The Journal of Neuroscience, 28(9), 2075-2088. https://doi.org/10.1523/JNEUROSCI.5258-07.2008</Citation></Reference><Reference><Citation>Jefferson, L. S., &amp; Kimball, S. R. (2001). Translational control of protein synthesis: Implications for understanding changes in skeletal muscle mass. International Journal of Sport Nutrition and Exercise Metabolism, 11(Suppl), S143-S149. https://doi.org/10.1123/ijsnem.11.s1.s143</Citation></Reference><Reference><Citation>Jensen, L., J&#xf8;rgensen, L. H., Bech, R. D., Frandsen, U., &amp; Schr&#xf8;der, H. D. (2016). Skeletal muscle remodelling as a function of disease progression in amyotrophic lateral sclerosis. BioMed Research International, 2016, 5930621-5930621. https://doi.org/10.1155/2016/5930621</Citation></Reference><Reference><Citation>Johnson, A. E., Shu, H., Hauswirth, A. G., Tong, A., &amp; Davis, G. W. (2015). VCP-dependent muscle degeneration is linked to defects in a dynamic tubular lysosomal network in vivo. eLife, 4. https://doi.org/10.7554/eLife.07366</Citation></Reference><Reference><Citation>Jokic, N., Gonzalez de Aguilar, J. L., Dimou, L., Lin, S., Fergani, A., Ruegg, M. A., &#x2026; Loeffler, J. P. (2006). The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Reports, 7(11), 1162-1167. https://doi.org/10.1038/sj.embor.7400826</Citation></Reference><Reference><Citation>Jokic, N., Gonzalez de Aguilar, J. L., Pradat, P.-F., Dupuis, L., Echaniz-Laguna, A., Muller, A., &#x2026; Meininger, V. (2005). Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Annals of Neurology, 57(4), 553-556. https://doi.org/10.1002/ana.20420</Citation></Reference><Reference><Citation>Kaganovich, D., Kopito, R., &amp; Frydman, J. (2008). Misfolded proteins partition between two distinct quality control compartments. Nature, 454(7208), 1088-1095. https://doi.org/10.1038/nature07195</Citation></Reference><Reference><Citation>Kamelgarn, M., Chen, J., Kuang, L., Jin, H., Kasarskis, E. J., &amp; Zhu, H. (2018). ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proceedings of the National Academy of Sciences of the United States of America, 115(51), E11904-E11913. https://doi.org/10.1073/pnas.1810413115</Citation></Reference><Reference><Citation>Kanekura, K., Yagi, T., Cammack, A. J., Mahadevan, J., Kuroda, M., Harms, M. B., &#x2026; Urano, F. (2016). Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Human Molecular Genetics, 25(9), 1803-1813. https://doi.org/10.1093/hmg/ddw052</Citation></Reference><Reference><Citation>Kasarskis, E. J., Mendiondo, M. S., Matthews, D. E., Mitsumoto, H., Tandan, R., Simmons, Z., &#x2026; Kryscio, R. J. (2014). Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis. The American Journal of Clinical Nutrition, 99(4), 792-803. https://doi.org/10.3945/ajcn.113.069997</Citation></Reference><Reference><Citation>Kato, N., Hashida, G., &amp; Konaka, K. (2018). Effect of muscle strengthening exercise and time since onset in patients with amyotrophic lateral sclerosis: A 2-patient case series study. Medicine, 97(25), e11145-e11145. https://doi.org/10.1097/MD.0000000000011145</Citation></Reference><Reference><Citation>King, I. N., Yartseva, V., Salas, D., Kumar, A., Heidersbach, A., Ando, D. M., &#x2026; Ivey, K. N. (2014). The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex. The Journal of Biological Chemistry, 289(20), 14263-14271. https://doi.org/10.1074/jbc.M114.561902</Citation></Reference><Reference><Citation>Kitamata, M., Hanawa-Suetsugu, K., Maruyama, K., &amp; Suetsugu, S. (2019). Membrane-deformation ability of ANKHD1 is involved in the early endosome enlargement. iScience, 17, 101-118. https://doi.org/10.1016/j.isci.2019.06.020</Citation></Reference><Reference><Citation>Kj&#xf8;bsted, R., Hingst, J. R., Fentz, J., Foretz, M., Sanz, M.-N., Pehm&#xf8;ller, C., &#x2026; Lantier, L. (2018). AMPK in skeletal muscle function and metabolism. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 32(4), 1741-1777. https://doi.org/10.1096/fj.201700442R</Citation></Reference><Reference><Citation>Kustermann, M., Manta, L., Paone, C., Kustermann, J., Lausser, L., Wiesner, C., &#x2026; Just, S. (2018). Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo. Autophagy, 14(11), 1911-1927. https://doi.org/10.1080/15548627.2018.1491491</Citation></Reference><Reference><Citation>Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., &#x2026; The North America ALS/IGF-I Study Group. (1997). Effect of recombinant human insulin-like growth factor-I on progression of ALS: A placebo-controlled study. Neurology, 49(6), 1621-1630. https://doi.org/10.1212/wnl.49.6.1621</Citation></Reference><Reference><Citation>Leclerc, N., Ribera, F., Zoll, J., Warter, J. M., Poindron, P., Lampert, E., &amp; Borg, J. (2001). Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice. Neuromuscular Disorders, 11(8), 722-727. https://doi.org/10.1016/s0960-8966(01)00240-1</Citation></Reference><Reference><Citation>Lepore, E., Casola, I., Dobrowolny, G., &amp; Musaro, A. (2019). Neuromuscular junction as an entity of nerve-muscle communication. Cell, 8(8). https://doi.org/10.3390/cells8080906</Citation></Reference><Reference><Citation>Li, X., Lu, L., Bush, D. J., Zhang, X., Zheng, L., Suswam, E. A., &amp; King, P. H. (2009). Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3&#x2032;-untranslated region. Journal of Neurochemistry, 108(4), 1032-1044. https://doi.org/10.1111/j.1471-4159.2008.05856.x</Citation></Reference><Reference><Citation>Lino, M. M., Schneider, C., &amp; Caroni, P. (2002). Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. The Journal of Neuroscience, 22(12), 4825-4832.</Citation></Reference><Reference><Citation>Liu, J. X., Brannstrom, T., Andersen, P. M., &amp; Pedrosa-Domellof, F. (2013). Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors. PLoS ONE, 8(2), e57473. https://doi.org/10.1371/journal.pone.0057473</Citation></Reference><Reference><Citation>Loeffler, J. P., Picchiarelli, G., Dupuis, L., &amp; Gonzalez De Aguilar, J. L. (2016). The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathology, 26(2), 227-236. https://doi.org/10.1111/bpa.12350</Citation></Reference><Reference><Citation>Lu, L., Zheng, L., Viera, L., Suswam, E., Li, Y., Li, X., &#x2026; King, P. H. (2007). Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. The Journal of Neuroscience, 27(30), 7929-7938. https://doi.org/10.1523/jneurosci.1877-07.2007</Citation></Reference><Reference><Citation>Lynch, E., Semrad, T., Belsito, V. S., FitzGibbons, C., Reilly, M., Hayakawa, K., &amp; Suzuki, M. (2019). Related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells. Disease Models &amp; Mechanisms, 12(8). https://doi.org/10.1242/dmm.039552</Citation></Reference><Reference><Citation>Madaro, L., Passafaro, M., Sala, D., Etxaniz, U., Lugarini, F., Proietti, D., &#x2026; Puri, P. L. (2018). Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis. Nature Cell Biology, 20(8), 917-927. https://doi.org/10.1038/s41556-018-0151-y</Citation></Reference><Reference><Citation>Mahoney, D. J., Kaczor, J. J., Bourgeois, J., Yasuda, N., &amp; Tarnopolsky, M. A. (2006). Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle. Muscle &amp; Nerve, 33(6), 809-816. https://doi.org/10.1002/mus.20542</Citation></Reference><Reference><Citation>Malena, A., Pennuto, M., Tezze, C., Querin, G., D'Ascenzo, C., Silani, V., &#x2026; Vergani, L. (2013). Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. Acta Neuropathologica, 126(1), 109-121. https://doi.org/10.1007/s00401-013-1122-9</Citation></Reference><Reference><Citation>Manzano, R., Sorar&#xfa;, G., Grunseich, C., Fratta, P., Zuccaro, E., Pennuto, M., &amp; Rinaldi, C. (2018). Beyond motor neurons: Expanding the clinical spectrum in Kennedy's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 89(8), 808-812. https://doi.org/10.1136/jnnp-2017-316961</Citation></Reference><Reference><Citation>Manzano, R., Toivonen, J. M., Calvo, A. C., Olivan, S., Zaragoza, P., Munoz, M. J., &#x2026; Osta, R. (2012). Quantity and activation of myofiber-associated satellite cells in a mouse model of amyotrophic lateral sclerosis. Stem Cell Reviews and Reports, 8(1), 279-287. https://doi.org/10.1007/s12015-011-9268-0</Citation></Reference><Reference><Citation>Manzano, R., Toivonen, J. M., Calvo, A. C., Olivan, S., Zaragoza, P., Rodellar, C., &#x2026; Osta, R. (2013). Altered in vitro proliferation of mouse SOD1-G93A skeletal muscle satellite cells. Neurodegenerative Diseases, 11(3), 153-164. https://doi.org/10.1159/000338061</Citation></Reference><Reference><Citation>Manzano, R., Toivonen, J. M., Olivan, S., Calvo, A. C., Moreno-Igoa, M., Munoz, M. J., &#x2026; Osta, R. (2011). Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis. Neurodegenerative Diseases, 8(5), 386-396. https://doi.org/10.1159/000324159</Citation></Reference><Reference><Citation>Manzano, R., Toivonen, J. M., Oliv&#xe1;n, S., Calvo, A. C., Moreno-Igoa, M., Mu&#xf1;oz, M. J., &#x2026; Osta, R. (2011). Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis. Neurodegenerative Diseases, 8(5), 386-396. https://doi.org/10.1159/000324159</Citation></Reference><Reference><Citation>Mattson, M. P., Cutler, R. G., &amp; Camandola, S. (2007). Energy intake and amyotrophic lateral sclerosis. Neuromolecular Medicine, 9(1), 17-20. https://doi.org/10.1385/NMM:9:1:17</Citation></Reference><Reference><Citation>Maurel, C., Dangoumau, A., Marouillat, S., Brulard, C., Chami, A., Hergesheimer, R., &#x2026; Vourc'h, P. (2018). Causative genes in amyotrophic lateral sclerosis and protein degradation pathways: A link to neurodegeneration. Molecular Neurobiology, 55(8), 6480-6499. https://doi.org/10.1007/s12035-017-0856-0</Citation></Reference><Reference><Citation>Miller, T. M., Kim, S. H., Yamanaka, K., Hester, M., Umapathi, P., Arnson, H., &#x2026; Kaspar, B. K. (2006). Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 103(51), 19546-19551. https://doi.org/10.1073/pnas.0609411103</Citation></Reference><Reference><Citation>Mora, J. S., Genge, A., Chio, A., Estol, C. J., Chaverri, D., Hern&#xe1;ndez, M., &#x2026; GROUP, A. S. (2020). Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: A randomized clinical trial. Amyotroph Lateral Scler Frontotemporal Degener, 21(1-2), 5-14. https://doi.org/10.1080/21678421.2019.1632346</Citation></Reference><Reference><Citation>Mori, F., Tada, M., Kon, T., Miki, Y., Tanji, K., Kurotaki, H., &#x2026; Wakabayashi, K. (2019). Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathologica Communications, 7(1), 165. https://doi.org/10.1186/s40478-019-0824-1</Citation></Reference><Reference><Citation>Napoli, L., Crugnola, V., Lamperti, C., Silani, V., Di Mauro, S., Bresolin, N., &amp; Moggio, M. (2011). Ultrastructural mitochondrial abnormalities in patients with sporadic amyotrophic lateral sclerosis. Archives of Neurology, 68(12), 1612-1613. https://doi.org/10.1001/archneur.68.12.1612</Citation></Reference><Reference><Citation>National Institutes of Health (NIH). NIH clinical trial database. https://clinicaltrials.gov/ct2/home</Citation></Reference><Reference><Citation>Nguyen, H. P., Van Broeckhoven, C., &amp; van der Zee, J. (2018). ALS genes in the genomic era and their implications for FTD. Trends in Genetics, 34(6), 404-423. https://doi.org/10.1016/j.tig.2018.03.001</Citation></Reference><Reference><Citation>Nishimoto, Y., Nakagawa, S., Hirose, T., Okano, H. J., Takao, M., Shibata, S., &#x2026; Okano, H. (2013). The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Molecular Brain, 6, 31. https://doi.org/10.1186/1756-6606-6-31</Citation></Reference><Reference><Citation>Nishimura, A. L., Mitne-Neto, M., Silva, H. C. A., Richieri-Costa, A., Middleton, S., Cascio, D., &#x2026; Zatz, M. (2004). A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. American Journal of Human Genetics, 75(5), 822-831. https://doi.org/10.1086/425287</Citation></Reference><Reference><Citation>Oliv&#xe1;n, S., Calvo, A. C., Gasco, S., Mu&#xf1;oz, M. J., Zaragoza, P., &amp; Osta, R. (2015). Time-point dependent activation of autophagy and the UPS in SOD1G93A mice skeletal muscle. PLoS ONE, 10(8), e0134830. https://doi.org/10.1371/journal.pone.0134830</Citation></Reference><Reference><Citation>Oliv&#xe1;n, S., Mart&#xed;nez-Beamonte, R., Calvo, A. C., Surra, J. C., Manzano, R., Arnal, C., &#x2026; Osada, J. (2014). Extra virgin olive oil intake delays the development of amyotrophic lateral sclerosis associated with reduced reticulum stress and autophagy in muscle of SOD1G93A mice. The Journal of Nutritional Biochemistry, 25(8), 885-892. https://doi.org/10.1016/j.jnutbio.2014.04.005</Citation></Reference><Reference><Citation>Onesto, E., Rusmini, P., Crippa, V., Ferri, N., Zito, A., Galbiati, M., &amp; Poletti, A. (2011). Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis. Journal of Neurochemistry, 118(2), 266-280. https://doi.org/10.1111/j.1471-4159.2011.07298.x</Citation></Reference><Reference><Citation>Palamiuc, L., Schlagowski, A., Ngo, S. T., Vernay, A., Dirrig-Grosch, S., Henriques, A., &#x2026; Ren&#xe9;, F. (2015). A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Molecular Medicine, 7(5), 526-546. https://doi.org/10.15252/emmm.201404433</Citation></Reference><Reference><Citation>Palomo, G. M., Granatiero, V., Kawamata, H., Konrad, C., Kim, M., Arreguin, A. J., &#x2026; Manfredi, G. (2018). Parkin is a disease modifier in the mutant SOD1 mouse model of ALS. EMBO Molecular Medicine, 10(10). https://doi.org/10.15252/emmm.201808888</Citation></Reference><Reference><Citation>Pegoraro, V., Marozzo, R., &amp; Angelini, C. (2020). MicroRNAs and HDAC4 protein expression in the skeletal muscle of ALS patients. Clinical Neuropathology. https://doi.org/10.5414/np301233</Citation></Reference><Reference><Citation>Picchiarelli, G., Demestre, M., Zuko, A., Been, M., Higelin, J., Dieterl&#xe9;, S., &#x2026; Storkebaum, E. (2019). FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nature Neuroscience, 22(11), 1793-1805. https://doi.org/10.1038/s41593-019-0498-9</Citation></Reference><Reference><Citation>Picchiarelli, G., &amp; Dupuis, L. (2020). Role of RNA binding proteins with prion-like domains in muscle and neuromuscular diseases. Cell Stress, 4(4), 76-91. https://doi.org/10.15698/cst2020.04.217</Citation></Reference><Reference><Citation>Pigna, E., Simonazzi, E., Sanna, K., Bernadzki, K. M., Proszynski, T., Heil, C., &#x2026; Moresi, V. (2019). Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. eBioMedicine, 40, 717-732. https://doi.org/10.1016/j.ebiom.2019.01.038</Citation></Reference><Reference><Citation>Pradat, P.-F., Barani, A., Wanschitz, J., Dubourg, O., Lomb&#xe8;s, A., Bigot, A., &#x2026; Butler-Browne, G. (2011). Abnormalities of satellite cells function in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 12(4), 264-271. https://doi.org/10.3109/17482968.2011.566618</Citation></Reference><Reference><Citation>Pradat, P.-F., Bruneteau, G., Gonzalez de Aguilar, J. L., Dupuis, L., Jokic, N., Salachas, F., &#x2026; Meininger, V. (2007). Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Annals of Neurology, 62(1), 15-20. https://doi.org/10.1002/ana.21122</Citation></Reference><Reference><Citation>Pradat, P.-F., Bruneteau, G., Gordon, P. H., Dupuis, L., Bonnefont-Rousselot, D., Simon, D., &#x2026; Meininger, V. (2010). Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 11(1-2), 166-171. https://doi.org/10.3109/17482960902822960</Citation></Reference><Reference><Citation>Pramatarova, A., Laganiere, J., Roussel, J., Brisebois, K., &amp; Rouleau, G. A. (2001). Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. The Journal of Neuroscience, 21(10), 3369-3374.</Citation></Reference><Reference><Citation>Pun, S., Santos, A. F., Saxena, S., Xu, L., &amp; Caroni, P. (2006). Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nature Neuroscience, 9(3), 408-419. https://doi.org/10.1038/nn1653</Citation></Reference><Reference><Citation>Rando, A., Gasco, S., de la Torre, M., Garc&#xed;a-Redondo, A., Zaragoza, P., Toivonen, J. M., &amp; Osta, R. (2017). Granulocyte colony-stimulating factor ameliorates skeletal muscle dysfunction in amyotrophic lateral sclerosis mice and improves proliferation of SOD1-G93A myoblasts in vitro. Neuro-Degenerative Diseases, 17(1), 1-13. https://doi.org/10.1159/000446113</Citation></Reference><Reference><Citation>Rando, A., Pastor, D., Viso-Le&#xf3;n, M. C., Mart&#xed;nez, A., Manzano, R., Navarro, X., &#x2026; Mart&#xed;nez, S. (2018). Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1G93A mice and modulates expression of prognosis biomarkers of the disease. Stem Cell Research &amp; Therapy, 9(1), 90-90. https://doi.org/10.1186/s13287-018-0843-z</Citation></Reference><Reference><Citation>Reyes, E. T., Perurena, O. H., Festoff, B. W., Jorgensen, R., &amp; Moore, W. V. (1984). Insulin resistance in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 63(3), 317-324. https://doi.org/10.1016/0022-510x(84)90154-0</Citation></Reference><Reference><Citation>Riddoch-Contreras, J., Yang, S. Y., Dick, J. R., Goldspink, G., Orrell, R. W., &amp; Greensmith, L. (2009). Mechano-growth factor, an IGF-I splice variant, rescues motoneurons and improves muscle function in SOD1G93A mice. Experimental Neurology, 215(2), 281-289. https://doi.org/10.1016/j.expneurol.2008.10.014</Citation></Reference><Reference><Citation>Ritson, G. P., Custer, S. K., Freibaum, B. D., Guinto, J. B., Geffel, D., Moore, J., &#x2026; Taylor, J. P. (2010). TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. The Journal of Neuroscience, 30(22), 7729-7739. https://doi.org/10.1523/JNEUROSCI.5894-09.2010</Citation></Reference><Reference><Citation>Rocchi, A., Milioto, C., Parodi, S., Armirotti, A., Borgia, D., Pellegrini, M., &#x2026; Pennuto, M. (2016). Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathologica, 132(1), 127-144. https://doi.org/10.1007/s00401-016-1550-4</Citation></Reference><Reference><Citation>Rosenfeld, J., King, R. M., Jackson, C. E., Bedlack, R. S., Barohn, R. J., Dick, A., &#x2026; Lou, J.-S. (2008). Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 9(5), 266-272. https://doi.org/10.1080/17482960802028890</Citation></Reference><Reference><Citation>Rusmini, P., Cristofani, R., Galbiati, M., Cicardi, M. E., Meroni, M., Ferrari, V., &#x2026; Poletti, A. (2017). The role of the heat shock protein B8 (HSPB8) in motoneuron diseases. Frontiers in Molecular Neuroscience, 10, 176. https://doi.org/10.3389/fnmol.2017.00176</Citation></Reference><Reference><Citation>Russell, A. P., Wada, S., Vergani, L., Hock, M. B., Lamon, S., L&#xe9;ger, B., &#x2026; Akimoto, T. (2013). Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiology of Disease, 49, 107-117. https://doi.org/10.1016/j.nbd.2012.08.015</Citation></Reference><Reference><Citation>Sandri, M. (2013). Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome. The International Journal of Biochemistry &amp; Cell Biology, 45(10), 2121-2129. https://doi.org/10.1016/j.biocel.2013.04.023</Citation></Reference><Reference><Citation>Scaramozza, A., Marchese, V., Papa, V., Salaroli, R., Sorar&#xf9;, G., Angelini, C., &amp; Cenacchi, G. (2014). Skeletal muscle satellite cells in amyotrophic lateral sclerosis. Ultrastructural Pathology, 38(5), 295-302. https://doi.org/10.3109/01913123.2014.937842</Citation></Reference><Reference><Citation>Scaricamazza, S., Salvatori, I., Giacovazzo, G., Loeffler, J. P., Ren&#xe8;, F., Rosina, M., &#x2026; Ferri, A. (2020). Skeletal-muscle metabolic reprogramming in ALS-SOD1G93A mice predates disease onset and is a promising therapeutic target. iScience, 23(5), 101087. https://doi.org/10.1016/j.isci.2020.101087</Citation></Reference><Reference><Citation>Schiaffino, S., Pereira, M. G., Ciciliot, S., &amp; Rovere-Querini, P. (2017). Regulatory T cells and skeletal muscle regeneration. The FEBS Journal, 284(4), 517-524. https://doi.org/10.1111/febs.13827</Citation></Reference><Reference><Citation>Sharma, A., Lyashchenko, A. K., Lu, L., Nasrabady, S. E., Elmaleh, M., Mendelsohn, M., &#x2026; Shneider, N. A. (2016). ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nature Communications, 7, 10465. https://doi.org/10.1038/ncomms10465</Citation></Reference><Reference><Citation>Shaw, M. P., Higginbottom, A., McGown, A., Castelli, L. M., James, E., Hautbergue, G. M., &#x2026; Ramesh, T. M. (2018). Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Acta Neuropathologica Communications, 6(1), 125. https://doi.org/10.1186/s40478-018-0629-7</Citation></Reference><Reference><Citation>Skulachev, V. P. (1996). Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Quarterly Reviews of Biophysics, 29(2), 169-202. https://doi.org/10.1017/s0033583500005795</Citation></Reference><Reference><Citation>Sorenson, E. J., Windbank, A. J., Mandrekar, J. N., Bamlet, W. R., Appel, S. H., Armon, C., &#x2026; Thornton, C. A. (2008). Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology, 71(22), 1770-1775. https://doi.org/10.1212/01.wnl.0000335970.78664.36</Citation></Reference><Reference><Citation>Spiller, K. J., Cheung, C. J., Restrepo, C. R., Kwong, L. K., Stieber, A. M., Trojanowski, J. Q., &amp; Lee, V. M. (2016). Selective motor neuron resistance and recovery in a new inducible mouse model of TDP-43 proteinopathy. The Journal of Neuroscience, 36(29), 7707-7717. https://doi.org/10.1523/JNEUROSCI.1457-16.2016</Citation></Reference><Reference><Citation>Stallings, N. R., Puttaparthi, K., Dowling, K. J., Luther, C. M., Burns, D. K., Davis, K., &amp; Elliott, J. L. (2013). TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS ONE, 8(8), e71793. https://doi.org/10.1371/journal.pone.0071793</Citation></Reference><Reference><Citation>Strah, N., Romano, G., Introna, C., Klima, R., Marzullo, M., Ciapponi, L., &#x2026; Feiguin, F. (2020). TDP-43 promotes the formation of neuromuscular synapses through the regulation of Disc-large expression in Drosophila skeletal muscles. BMC Biology, 18(1), 34. https://doi.org/10.1186/s12915-020-00767-7</Citation></Reference><Reference><Citation>Suzuki, M., McHugh, J., Tork, C., Shelley, B., Hayes, A., Bellantuono, I., &#x2026; Svendsen, C. N. (2008). Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Molecular Therapy: The Journal of the American Society of Gene Therapy, 16(12), 2002-2010. https://doi.org/10.1038/mt.2008.197</Citation></Reference><Reference><Citation>Swartz, E. W., Baek, J., Pribadi, M., Wojta, K. J., Almeida, S., Karydas, A., &#x2026; Coppola, G. (2016). A novel protocol for directed differentiation of C9orf72-associated human induced pluripotent stem cells into contractile skeletal myotubes. Stem Cells Translational Medicine, 5(11), 1461-1472. https://doi.org/10.5966/sctm.2015-0340</Citation></Reference><Reference><Citation>Thau, N., Knippenberg, S., K&#xf6;rner, S., Rath, K. J., Dengler, R., &amp; Petri, S. (2012). Decreased mRNA expression of PGC-1&#x3b1; and PGC-1&#x3b1;-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. Journal of Neuropathology and Experimental Neurology, 71(12), 1064-1074. https://doi.org/10.1097/NEN.0b013e318275df4b</Citation></Reference><Reference><Citation>Tidball, J. G. (2017). Regulation of muscle growth and regeneration by the immune system. Nature Reviews Immunology, 17(3), 165-178. https://doi.org/10.1038/nri.2016.150</Citation></Reference><Reference><Citation>Tipton, K. D., Hamilton, D. L., &amp; Gallagher, I. J. (2018). Assessing the role of muscle protein breakdown in response to nutrition and exercise in humans. Sports Medicine, 48(Suppl 1), 53-64. https://doi.org/10.1007/s40279-017-0845-5</Citation></Reference><Reference><Citation>Toivonen, J. M., Manzano, R., Oliv&#xe1;n, S., Zaragoza, P., Garc&#xed;a-Redondo, A., &amp; Osta, R. (2014). MicroRNA-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE, 9(2), e89065. https://doi.org/10.1371/journal.pone.0089065</Citation></Reference><Reference><Citation>Tokutake, Y., Yamada, K., Ohata, M., Obayashi, Y., Tsuchiya, M., &amp; Yonekura, S. (2015). ALS-linked P56S-VAPB mutation impairs the formation of multinuclear myotube in C2C12 cells. International Journal of Molecular Sciences, 16(8), 18628-18641. https://doi.org/10.3390/ijms160818628</Citation></Reference><Reference><Citation>Trias, E., Ibarburu, S., Barreto-N&#xfa;&#xf1;ez, R., Varela, V., Moura, I. C., Dubreuil, P., &#x2026; Barbeito, L. (2017). Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS. JCI Insight, 2(20). https://doi.org/10.1172/jci.insight.95934</Citation></Reference><Reference><Citation>Trias, E., King, P. H., Si, Y., Kwon, Y., Varela, V., Ibarburu, S., &#x2026; Barbeito, L. (2018). Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight, 3(19), e123249. https://doi.org/10.1172/jci.insight.123249</Citation></Reference><Reference><Citation>Tsitkanou, S., Della Gatta, P., Foletta, V., &amp; Russell, A. (2019). The role of exercise as a non-pharmacological therapeutic approach for amyotrophic lateral sclerosis: Beneficial or detrimental? Frontiers in Neurology, 10, 783. https://doi.org/10.3389/fneur.2019.00783</Citation></Reference><Reference><Citation>Vainshtein, A., &amp; Sandri, M. (2020). Signaling pathways that control muscle mass. International Journal of Molecular Sciences, 21(13). https://doi.org/10.3390/ijms21134759</Citation></Reference><Reference><Citation>Van Dyke, J. M., Smit-Oistad, I. M., Macrander, C., Krakora, D., Meyer, M. G., &amp; Suzuki, M. (2016). Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Experimental Neurology, 277, 275-282. https://doi.org/10.1016/j.expneurol.2016.01.008</Citation></Reference><Reference><Citation>Vergouts, M., Marinangeli, C., Ingelbrecht, C., Genard, G., Schakman, O., Sternotte, A., &#x2026; Hermans, E. (2015). Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease. Metabolic Brain Disease, 30(6), 1369-1377. https://doi.org/10.1007/s11011-015-9706-9</Citation></Reference><Reference><Citation>Vielhaber, S., Kunz, D., Winkler, K., Wiedemann, F. R., Kirches, E., Feistner, H., &#x2026; Kunz, W. S. (2000). Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain, 123(Pt 7), 1339-1348. https://doi.org/10.1093/brain/123.7.1339</Citation></Reference><Reference><Citation>Vogler, T. O., Wheeler, J. R., Nguyen, E. D., Hughes, M. P., Britson, K. A., Lester, E., &#x2026; Parker, R. (2018). TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle. Nature, 563(7732), 508-513. https://doi.org/10.1038/s41586-018-0665-2</Citation></Reference><Reference><Citation>Wang, H. A., Lee, J. D., Lee, K. M., Woodruff, T. M., &amp; Noakes, P. G. (2017). Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Skeletal Muscle, 7(1), 10. https://doi.org/10.1186/s13395-017-0128-8</Citation></Reference><Reference><Citation>Wang, L., Sharma, K., Deng, H. X., Siddique, T., Grisotti, G., Liu, E., &amp; Roos, R. P. (2008). Restricted expression of mutant SOD1 in spinal motor neurons and interneurons induces motor neuron pathology. Neurobiology of Disease, 29(3), 400-408. https://doi.org/10.1016/j.nbd.2007.10.004</Citation></Reference><Reference><Citation>Wei, R., Bhattacharya, A., Hamilton, R. T., Jernigan, A. L., &amp; Chaudhuri, A. R. (2013). Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: Role of chaperone network. Biochemical and Biophysical Research Communications, 438(1), 218-223. https://doi.org/10.1016/j.bbrc.2013.07.060</Citation></Reference><Reference><Citation>Wendt, S., Dedeoglu, A., Speer, O., Wallimann, T., Beal, M. F., &amp; Andreassen, O. A. (2002). Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice. Free Radical Biology &amp; Medicine, 32(9), 920-926. https://doi.org/10.1016/s0891-5849(02)00784-0</Citation></Reference><Reference><Citation>Wiedemann, F. R., Winkler, K., Kuznetsov, A. V., Bartels, C., Vielhaber, S., Feistner, H., &amp; Kunz, W. S. (1998). Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 156(1), 65-72. https://doi.org/10.1016/s0022-510x(98)00008-2</Citation></Reference><Reference><Citation>Williams, A. H., Valdez, G., Moresi, V., Qi, X., McAnally, J., Elliott, J. L., &#x2026; Olson, E. N. (2009). MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science (New York, N.Y.), 326(5959), 1549-1554. https://doi.org/10.1126/science.1181046</Citation></Reference><Reference><Citation>Wojcik, S., Engel, W. K., &amp; Askanas, V. (2006). Increased expression of Noga-A in ALS muscle biopsies is not unique for this disease. Acta Myologica, 25(3), 116-118.</Citation></Reference><Reference><Citation>Wong, M., &amp; Martin, L. J. (2010). Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Human Molecular Genetics, 19(11), 2284-2302. https://doi.org/10.1093/hmg/ddq106</Citation></Reference><Reference><Citation>Woodruff, T. M., Costantini, K. J., Crane, J. W., Atkin, J. D., Monk, P. N., Taylor, S. M., &amp; Noakes, P. G. (2008). The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. The Journal of Immunology, 181(12), 8727. https://doi.org/10.4049/jimmunol.181.12.8727</Citation></Reference><Reference><Citation>Woodruff, T. M., Lee, J. D., &amp; Noakes, P. G. (2014). Role for terminal complement activation in amyotrophic lateral sclerosis disease progression. Proceedings of the National Academy of Sciences of the United States of America, 111, E3-E4.</Citation></Reference><Reference><Citation>Xiao, Y., Karam, C., Yi, J., Zhang, L., Li, X., Yoon, D., &#x2026; Zhou, J. (2018). ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression. Pharmacological Research, 138, 25-36. https://doi.org/10.1016/j.phrs.2018.09.008</Citation></Reference><Reference><Citation>Xiao, Y., Ma, C., Yi, J., Wu, S., Luo, G., Xu, X., &#x2026; Zhou, J. (2015). Suppressed autophagy flux in skeletal muscle of an amyotrophic lateral sclerosis mouse model during disease progression. Physiological Reports, 3(1). https://doi.org/10.14814/phy2.12271</Citation></Reference><Reference><Citation>Yamanaka, K., Boillee, S., Roberts, E. A., Garcia, M. L., McAlonis-Downes, M., Mikse, O. R., &#x2026; Goldstein, L. S. (2008). Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proceedings of the National Academy of Sciences of the United States of America, 105(21), 7594-7599. https://doi.org/10.1073/pnas.0802556105</Citation></Reference><Reference><Citation>Yoo, Y. E., &amp; Ko, C. P. (2012). Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice. PLoS ONE, 7(5), e37258. https://doi.org/10.1371/journal.pone.0037258</Citation></Reference><Reference><Citation>Zhao, M., Kim, J. R., van Bruggen, R., &amp; Park, J. (2018). RNA-binding proteins in amyotrophic lateral sclerosis. Molecules and Cells, 41(9), 818-829. https://doi.org/10.14348/molcells.2018.0243</Citation></Reference><Reference><Citation>Zhu, M., Zhang, S., Tian, X., &amp; Wu, C. (2017). Mask mitigates MAPT- and FUS-induced degeneration by enhancing autophagy through lysosomal acidification. Autophagy, 13(11), 1924-1938. https://doi.org/10.1080/15548627.2017.1362524</Citation></Reference><Reference><Citation>Zorov, D. B., Juhaszova, M., &amp; Sollott, S. J. (2014). Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological Reviews, 94(3), 909-950. https://doi.org/10.1152/physrev.00026.2013</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>